Novo Nordisk faces setback as CLARION-CKD trial fails, leading to significant financial impairment
Novo Nordisk, a global leader in pharmaceuticals, has announced a major setback as its CLARION-CKD phase 3 trial failed to meet its primary endpoint, prompting ... Read More
Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets
Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More
Zydus Lifesciences gains tentative FDA approval for hypertension drug
Zydus Lifesciences Limited has achieved a significant milestone by receiving tentative approval from the United States Food and Drug Administration (USFDA) to market its combination ... Read More
Mylan launches generic hypertension drugs Benicar and Benicar HCT in US
Global pharmaceutical giant Mylan has made a significant stride in the hypertension treatment market with the US launch of the first generic versions of Daiichi ... Read More